185 related articles for article (PubMed ID: 38362027)
1. Gut microbial diversity moderates polygenic risk of schizophrenia.
Zhang L; Yuan X; Li X; Zhang X; Mao Y; Hu S; Andreassen OA; Wang Y; Song X
Front Psychiatry; 2024; 15():1275719. PubMed ID: 38362027
[TBL] [Abstract][Full Text] [Related]
2. [The influence of interaction between polygenic risk score and intestinal fungal microbiota on the risk of schizophrenia].
Yuan XX; Sun Y; Pang LJ; Li X; Hei GR; Zhang XY; Li JJ; Song XQ
Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(30):2324-2329. PubMed ID: 37574830
[No Abstract] [Full Text] [Related]
3. Associations Between Polygenic Risk Score Loading, Psychosis Liability, and Clozapine Use Among Individuals With Schizophrenia.
Lin BD; Pinzón-Espinosa J; Blouzard E; van der Horst MZ; Okhuijsen-Pfeifer C; van Eijk KR; Guloksuz S; Peyrot WJ; Luykx JJ;
JAMA Psychiatry; 2023 Feb; 80(2):181-185. PubMed ID: 36542388
[TBL] [Abstract][Full Text] [Related]
4. Polygenic risk scores in schizophrenia with clinically significant copy number variants.
Taniguchi S; Ninomiya K; Kushima I; Saito T; Shimasaki A; Sakusabe T; Momozawa Y; Kubo M; Kamatani Y; Ozaki N; Ikeda M; Iwata N
Psychiatry Clin Neurosci; 2020 Jan; 74(1):35-39. PubMed ID: 31461559
[TBL] [Abstract][Full Text] [Related]
5. Comparison of gut microbiome profile in patients with schizophrenia and healthy controls - A plausible non-invasive biomarker?
Gokulakrishnan K; Nikhil J; Viswanath B; Thirumoorthy C; Narasimhan S; Devarajan B; Joseph E; David AKD; Sharma S; Vasudevan K; Sreeraj VS; Holla B; Shivakumar V; Debnath M; Venkatasubramanian G; Varambally S
J Psychiatr Res; 2023 Jun; 162():140-149. PubMed ID: 37156128
[TBL] [Abstract][Full Text] [Related]
6. Associations between major psychiatric disorder polygenic risk scores and blood-based markers in UK biobank.
Sewell MDE; Jiménez-Sánchez L; Shen X; Edmondson-Stait AJ; Green C; Adams MJ; Rifai OM; McIntosh AM; Lyall DM; Whalley HC; Lawrie SM
Brain Behav Immun; 2021 Oct; 97():32-41. PubMed ID: 34107350
[TBL] [Abstract][Full Text] [Related]
7. Stratifying major depressive disorder by polygenic risk for schizophrenia in relation to structural brain measures.
Harris MA; Shen X; Cox SR; Gibson J; Adams MJ; Clarke TK; Deary IJ; Lawrie SM; McIntosh AM; Whalley HC
Psychol Med; 2020 Jul; 50(10):1653-1662. PubMed ID: 31317844
[TBL] [Abstract][Full Text] [Related]
8. Differences in Alpha Diversity of Gut Microbiota in Neurological Diseases.
Li Z; Zhou J; Liang H; Ye L; Lan L; Lu F; Wang Q; Lei T; Yang X; Cui P; Huang J
Front Neurosci; 2022; 16():879318. PubMed ID: 35837118
[TBL] [Abstract][Full Text] [Related]
9. Cognitive performances across individuals at high genetic risk for schizophrenia, high genetic risk for bipolar disorder, and low genetic risks: a combined polygenic risk score approach.
Ohi K; Nishizawa D; Sugiyama S; Takai K; Fujikane D; Kuramitsu A; Hasegawa J; Soda M; Kitaichi K; Hashimoto R; Ikeda K; Shioiri T
Psychol Med; 2023 Jul; 53(10):4454-4463. PubMed ID: 35971752
[TBL] [Abstract][Full Text] [Related]
10. The effect of polygenic risk scores for major depressive disorder, bipolar disorder and schizophrenia on morphological brain measures: A systematic review of the evidence.
Cattarinussi G; Delvecchio G; Sambataro F; Brambilla P
J Affect Disord; 2022 Aug; 310():213-222. PubMed ID: 35533776
[TBL] [Abstract][Full Text] [Related]
11. Multiomics Analyses Reveal Microbiome-Gut-Brain Crosstalk Centered on Aberrant Gamma-Aminobutyric Acid and Tryptophan Metabolism in Drug-Naïve Patients with First-Episode Schizophrenia.
Wang Z; Yuan X; Zhu Z; Pang L; Ding S; Li X; Kang Y; Hei G; Zhang L; Zhang X; Wang S; Jian X; Li Z; Zheng C; Fan X; Hu S; Shi Y; Song X
Schizophr Bull; 2024 Jan; 50(1):187-198. PubMed ID: 37119525
[TBL] [Abstract][Full Text] [Related]
12. A polygenic resilience score moderates the genetic risk for schizophrenia: Replication in 18,090 cases and 28,114 controls from the Psychiatric Genomics Consortium.
Hess JL; Mattheisen M; ; Greenwood TA; Tsuang MT; Edenberg HJ; Holmans P; Faraone SV; Glatt SJ
Am J Med Genet B Neuropsychiatr Genet; 2024 Mar; 195(2):e32957. PubMed ID: 37551635
[TBL] [Abstract][Full Text] [Related]
13. Examining the independent and joint effects of genomic and exposomic liabilities for schizophrenia across the psychosis spectrum.
Pries LK; Dal Ferro GA; van Os J; Delespaul P; Kenis G; Lin BD; Luykx JJ; Richards AL; Akdede B; Binbay T; Altınyazar V; Yalınçetin B; Gümüş-Akay G; Cihan B; Soygür H; Ulaş H; Şahin Cankurtaran E; Ulusoy Kaymak S; Mihaljevic MM; Andric Petrovic S; Mirjanic T; Bernardo M; Mezquida G; Amoretti S; Bobes J; Saiz PA; García-Portilla MP; Sanjuan J; Aguilar EJ; Santos JL; Jiménez-López E; Arrojo M; Carracedo A; López G; González-Peñas J; Parellada M; Maric NP; Atbaşoğlu C; Ucok A; Alptekin K; Can Saka M; ; Arango C; O'Donovan M; Tosato S; Rutten BPF; Guloksuz S
Epidemiol Psychiatr Sci; 2020 Nov; 29():e182. PubMed ID: 33200977
[TBL] [Abstract][Full Text] [Related]
14. Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles.
Oraki Kohshour M; Kannaiyan NR; Falk AJ; Papiol S; Heilbronner U; Budde M; Kalman JL; Schulte EC; Rietschel M; Witt S; Forstner AJ; Heilmann-Heimbach S; Nöthen MM; Spitzer C; Malchow B; Müller T; Wiltfang J; Falkai P; Schmitt A; Rossner MJ; Nilsson P; Schulze TG
Transl Psychiatry; 2022 Nov; 12(1):471. PubMed ID: 36351892
[TBL] [Abstract][Full Text] [Related]
15. The association of polygenic risk for schizophrenia, bipolar disorder, and depression with neural connectivity in adolescents and young adults: examining developmental and sex differences.
Meyers JL; Chorlian DB; Bigdeli TB; Johnson EC; Aliev F; Agrawal A; Almasy L; Anokhin A; Edenberg HJ; Foroud T; Goate A; Kamarajan C; Kinreich S; Nurnberger J; Pandey AK; Pandey G; Plawecki MH; Salvatore JE; Zhang J; Fanous A; Porjesz B
Transl Psychiatry; 2021 Jan; 11(1):54. PubMed ID: 33446638
[TBL] [Abstract][Full Text] [Related]
16. Polygenetic Risk Scores for Major Psychiatric Disorders Among Schizophrenia Patients, Their First-Degree Relatives, and Healthy Participants.
Ohi K; Nishizawa D; Shimada T; Kataoka Y; Hasegawa J; Shioiri T; Kawasaki Y; Hashimoto R; Ikeda K
Int J Neuropsychopharmacol; 2020 Apr; 23(3):157-164. PubMed ID: 31900488
[TBL] [Abstract][Full Text] [Related]
17. Profiling the differences of gut microbial structure between schizophrenia patients with and without violent behaviors based on 16S rRNA gene sequencing.
Chen X; Xu J; Wang H; Luo J; Wang Z; Chen G; Jiang D; Cao R; Huang H; Luo D; Xiao X; Hu J
Int J Legal Med; 2021 Jan; 135(1):131-141. PubMed ID: 33067643
[TBL] [Abstract][Full Text] [Related]
18. [Variations in fecal microbiota of first episode schizophrenia associated with clinical assessment and serum metabolomics].
Wang XP; Zhang YY; Lu TL; Lu Z; Kang ZW; Sun YY; Yue WH
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Oct; 54(5):863-873. PubMed ID: 36241229
[TBL] [Abstract][Full Text] [Related]
19. Increasing sample diversity in psychiatric genetics - Introducing a new cohort of patients with schizophrenia and controls from Vietnam - Results from a pilot study.
Nguyen VT; Braun A; Kraft J; Ta TMT; Panagiotaropoulou GM; Nguyen VP; Nguyen TH; Trubetskoy V; Le CT; Le TTH; Pham XT; Heuser-Collier I; Lam NH; Böge K; Hahne IM; Bajbouj M; Zierhut MM; Hahn E; Ripke S
World J Biol Psychiatry; 2022 Mar; 23(3):219-227. PubMed ID: 34449294
[TBL] [Abstract][Full Text] [Related]
20. Polygenic Risk of Schizophrenia and Cognition in a Population-Based Survey of Older Adults.
Liebers DT; Pirooznia M; Seiffudin F; Musliner KL; Zandi PP; Goes FS
Schizophr Bull; 2016 Jul; 42(4):984-91. PubMed ID: 26873889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
